RGNX in the 13F filings
Regenxbio Inc · CUSIP 75901B107
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 19 Feb 2026
- latest of these filings; the earliest 22 Jan 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 1 listed it in both
- Shares listed
- 4,020,397
- combined, among listed positions
- Reported value
- $58m
- combined, at the quarter end
Among the 92 comparable managers: 13 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +20,302.
Managers listing RGNX in Q4 2025
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 214,666 shares now+128,007
- AQR Capital Management LLCexisting position · 1,361,962 shares now+72,307
- Fidelity (FMR LLC)existing position · 266,095 shares now+70,905
- D. E. Shaw & Co.new position · 68,388 shares now+68,388
- ExodusPoint Capital Management LPnew position · 55,610 shares now+55,610
Reductions
- Squarepoint Ops LLCexisting position · 42,918 shares now-163,489
- Jane Street Group LLCexisting position · 196,521 shares now-94,641
- Susquehanna International Group LLPexisting position · 15,624 shares now-75,684
- Hudson Bay Capital Management LPexisting position · 140,000 shares now-60,000
- Man Group PLCexisting position · 63,571 shares now-48,827
New positions and exits
New (5)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2016 | 1 | $742k | n.a. | n.a. |
| Q1 2017 | 2 | $2.5m | n.a. | n.a. |
| Q2 2017 | 2 | $7.7m | n.a. | n.a. |
| Q3 2017 | 3 | $19m | n.a. | n.a. |
| Q4 2017 | 2 | $7.8m | n.a. | n.a. |
| Q1 2018 | 3 | $5.1m | n.a. | n.a. |
| Q2 2018 | 6 | $34m | n.a. | n.a. |
| Q3 2018 | 5 | $36m | n.a. | n.a. |
| Q4 2018 | 1 | $373k | n.a. | n.a. |
| Q1 2019 | 2 | $11m | n.a. | n.a. |
| Q2 2019 | 3 | $11m | n.a. | n.a. |
| Q3 2019 | 1 | $3.2m | n.a. | n.a. |
| Q4 2019 | 2 | $12m | n.a. | n.a. |
| Q1 2020 | 3 | $12m | n.a. | n.a. |
| Q2 2020 | 4 | $21m | n.a. | n.a. |
| Q3 2020 | 3 | $17m | n.a. | n.a. |
| Q4 2020 | 3 | $6.0m | n.a. | n.a. |
| Q1 2021 | 2 | $33m | n.a. | n.a. |
| Q2 2021 | 1 | $2.0m | n.a. | n.a. |
| Q1 2022 | 2 | $17m | n.a. | n.a. |
| Q2 2022 | 3 | $15m | n.a. | n.a. |
| Q3 2022 | 2 | $998k | n.a. | n.a. |
| Q4 2022 | 3 | $13m | n.a. | n.a. |
| Q1 2023 | 2 | $5.8m | n.a. | n.a. |
| Q2 2023 | 1 | $9.8m | n.a. | n.a. |
| Q3 2023 | 2 | $10m | n.a. | n.a. |
| Q4 2023 | 1 | $1.6m | 0 | 1 |
| Q1 2024 | 4 | $6.8m | 4 | 0 |
| Q2 2024 | 3 | $3.2m | 1 | 1 |
| Q3 2024 | 2 | $2.1m | 1 | 0 |
| Q4 2024 | 2 | $1.3m | 1 | 0 |
| Q1 2025 | 2 | $1.4m | 1 | 0 |
| Q2 2025 | 1 | $1.2m | 1 | 0 |
| Q3 2025 | 1 | $1.4m | 0 | 0 |
| Q4 2025 | 1 | $2.9m | 13 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
RGNX and GILD →RGNX and AMGN →RGNX and ARGX →Choose a stock to compare with RGNX →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own RGNX, latest filings →Back to the 13F Explorer →